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Abstract
Fetal growth defect is classified into intrauterine growth restriction (IUGR) and small-for-
gestational-age (SGA) fetus based on the estimated fetal weight percentile and Doppler 
hemodynamic parameters. IUGR pathophysiology and etiology are complex and diverse, 
highlighting placental insufficiency as a paradigm, which explains its association with 
other entities of great clinical importance such as preeclampsia. The poor long- and short-
term perinatal and postnatal results associated with this context make it necessary to 
establish an early diagnosis and a therapeutic strategy, which can be challenging due to the 
compromise between the threat of intrauterine permanence and the prematurity problem. 
Consequently, a systematic and protocolized diagnostic-therapeutic management, based 
on scientific evidence, is necessary to determine whether obstetric intervention through a 
preterm delivery is advisable to improve the perinatal outcomes of these patients.
Keywords: fetal growth, intrauterine growth restriction, small-for-gestational-age fetus, 
Doppler evaluation, prematurity
1. Introduction
In general terms, fetal growth defect is considered the impossibility of achieving the geneti-
cally determined potential size [1]. In the vast majority of cases, it is related to uteroplacen-
tal insufficiency in the context of intrauterine growth restriction (IUGR). Despite its origin 
remains unknown, it is believed to be caused by an interaction of environmental and genetic 
factors with either a fetal, placental, or maternal origin. Various complications are associated 
with IUGR; these may include stillbirth, prematurity, neonatal morbi-mortality, endocrine and 
metabolic alterations, increased cardiovascular risk, and long-term neurological sequelae [2].
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
IUGR fetus identification is one of the main objectives of prenatal care, since proper perinatal 
diagnosis and management reduces perinatal morbi-mortality [3]. Most small fetuses are not 
diagnosed during pregnancy [4], not even in high-risk subpopulations. This is in part due to 
the large number of reference tables used and the lack of international standards comparable 
to those for child growth [5]. Therefore, it is necessary to improve the prenatal diagnosis of 
these cases. With this purpose, it is essential to have an agreed definition between obstetri-
cians and neonatologists, which would allow to compare data, to conduct prospective stud-
ies, and to analyze results between different institutions [2].
2. Definitions
Fetal growth defect (FGD) is defined as an ultrasound estimated fetal weight (EFW) below the 
10th percentile for gestational age and gender [2].
Among FGD fetuses, Doppler hemodynamic evaluation differentiates fetuses with higher 
risk of perinatal morbi-mortality [6]. Hence, fetal growth restriction definition incorporates 
the Doppler hemodynamic evaluation to distinguish the fetuses with placental involvement 
from those without that affectation. These unaffected fetuses have a better prognosis and are 
known as small-for-gestational-age (SGA) fetuses [2].
Fetal weight estimation is based on Hadlock’s formula which includes biparietal diameter 
(BPD), head circumference (HC), abdominal circumference (AC), and femur length (FL) [7]. 
However, there is controversy about fetal weight percentile estimation in the medical litera-
ture. Percentile customization according to maternal and/or paternal features is one of the 
main sources of heterogeneity in the IUGR definition. The utility of customized percentiles 
is to a certain extent limited because factors used for customization are not powerful pre-
dictors of birth weight [8]. Maternal height, weight, and ethnicity/race are related to fetal 
size but do not explain the important variability in birth weight. Thus, the limitations of 
these parameters restrict their usefulness for IUGR definition [2]. For that reason, the Fetal 
Growth Longitudinal Study, part of the Intergrowth-21st Project, aimed to develop inter-
national tabulated standards for fetal growth [9]. These curves have the advantage of using 
fetal growth standards derived from healthy populations. This reduces the underdiagnosis 
that may occur when fetal growth is contrasted against references including the high-risk 
mothers. At the various study sites, these curves have proven to be similar for all fetal and 
newborn measurements showing the same growth potential regardless of the race [10]. 
Thus, the reported differences were probably related to nutritional problems rather than 
geographical location or ethnicity [2]. However, several subsequent studies have shown that 
individualized fetal growth tables improve the identification of patients at risk of adverse 
perinatal outcomes [11].
2.1. Differences between IUGR and SGA
A small fetus is associated with worse obstetric results. At least two groups of small fetuses 
are distinguished: IUGR and SGA [2]. Table 1 shows its main differences:
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IUGR term refers to small fetuses with a higher risk of intrauterine fetal deterioration, still-
birth, and, in general, a worse perinatal outcome than those with normal growth. These 
fetuses have a “true” growth delay and are generally associated with Doppler ultrasound 
signs which suggest hemodynamic redistribution due to an adaptation to fetal malnutrition/
hypoxia with histological and biochemical signs of placental disease. IUGR is also associated 
with an increased risk of preeclampsia [2].
2.2. IUGR vs. SGA definition
Current evidence suggests that there is no superior parameter for differentiating IUGR from 
SGA [2]. As for the individual Doppler ultrasound study, the best candidate is the cerebro-
placental ratio (CPR), which is calculated dividing the middle cerebral artery (MCA) Doppler 
pulsatility index (PI) (MCA-PI) by the umbilical artery (UA) Doppler PI (UA-PI). This ratio 
reflects small decreases in fetal cerebral vascular resistance with slight increases in placen-
tal resistance in a combined way. This relationship seems to be more sensitive to hypoxia 
than its individual components, correlating better with a possible adverse outcome [12]. The 
uterine artery (UtA) PI (UtA-PI) is a predictor of worse perinatal results in small fetuses [13]. 
Another poor outcome predictive factor is a very small EFW regardless of the CPR and the 
UtA-PI values. An EFW below the 3rd percentile indicates a much higher risk of adverse 
perinatal outcomes [14]. Therefore, when there are any of the three parameters mentioned 
above (CPR, UtA-PI, and/or EFW < 3rd percentile), the risk of adverse perinatal outcomes 
increases. For this reason, the definition of IUGR must include these three parameters [2].
Summarizing the definition [2, 15]:
• A SGA fetus is defined as an EFW lower than the 10th percentile and greater than or 
equal to the 3rd percentile for gestational age and gender with a normal Doppler hemo-
dynamic study.
• An IUGR is defined as:
 ○ An EFW below the 3rd percentile for gestational age and gender
 ○ An EFW below the 10th percentile for gestational age and gender plus an altered 
Doppler hemodynamic study
Table 1. Differences between IUGR and SGA.
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2.3. Severe early onset vs. moderate late onset IUGR
The IUGR is presented in two different phenotypes according to disease onset time during 
pregnancy: early onset IUGR and late onset IUGR. Generally, there is a correlation between 
early onset and more severe IUGR forms, so two types of IUGR are defined: severe early onset 
and moderate late onset. The cutoff point for these forms has been arbitrarily established at 
32 weeks [2]. In Table 2, we observe the differences between both clinical forms.
2.3.1. Severe early onset IUGR
The severe early onset IUGR represents 20–30% of all IUGR. It is related to severe placental 
insufficiency and chronic fetal hypoxia, and so UA Doppler is often pathological [16]. In this 
context, this type of IUGR is associated with early preeclampsia in up to 50% of cases [17] 
and with severe damage and/or stillbirth before term [18]. Besides, its clinical management 
is a challenge due to the necessity to balance the risks of intrauterine permanence with the 
complications derived from prematurity [2].
Without treatment, fetal well-being deteriorates with a progression toward hypoxia and aci-
dosis, which is reflected in the sequence of alterations of the UA Doppler and the PI of the 
ductus venosus (DV). The latency period to severe fetal deterioration is variable, but it usually 
lasts for weeks [19] and depends on the severity of the placental compromise. The sequence 
of changes (Figure 1) is relatively constant, especially in the signs of advanced stages, except 
in the cases where there is an associated preeclampsia which can distort the natural history. 
In such cases, fetal deterioration might appear unexpectedly. These changes in fetal Doppler 
allow for the monitorization of the progression of fetal deterioration and the scheduling of the 
delivery in an elective manner [2].
Table 2. Differences between severe early-onset IUGR vs. moderate late-onset IUGR (adapted from Ref. [2]).
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2.3.2. Moderate late onset IUGR
These fetuses represent 70–80% of cases [17]. The placental alteration is mild, and, therefore, 
the UA is generally normal [20] and there is low association with preeclampsia (10%) [17]. In 
these cases, the diagnostic rates are low, and that is what makes the late (undiagnosed) IUGR 
to contribute in a large proportion of late stillbirth [21].
In moderate lateonset IUGR, there is a high rate of CPR alteration [20]. In addition, in 25% 
of cases of late onset IUGR, a cerebral vasodilation may occur (MCA-PI below the 5th per-
centile), reflecting a situation of chronic hypoxia. Besides, signs of advanced fetal deteriora-
tion with changes in the ductus venosus are hardly ever observed [20]. For this reason, the 
sequential fetal deterioration cascade described previously does not occur (Figure 2). These 
fetuses may suffer rapid deterioration which can lead to serious injury or death. The explana-
tion behind this fact could be a combination of factors such as the low tolerance of preterm 
fetuses to hypoxia (compared to preterm fetuses), the higher frequency of uterine contrac-
tions in term gestations, and some cases of acute placental failure [2]. Despite the benign 
nature of this type of fetus, the risk of acute fetal deterioration before delivery significantly 
contributes to late stillbirth [22] and to a high association with intrapartum fetal distress and 
neonatal acidosis [23].
2.3.3. Common problems
Both IUGR types are associated with a worse long-term prognosis in neurological, cardio-
vascular, and metabolic development [24–27]. This would mean that, regardless of severity, 
chronic exposure to an adverse intrauterine environment is essential to develop adverse fetal 
programming. Predictably, different stages of fetal maturation would determine different 
adaptive programming responses [2].
Figure 1. Sequence of changes in severe early-onset IUGR. Adapted from Ref. [2].
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The evidence suggests that both early and late onset IUGR are a consequence of a placental 
disease, but it is unknown to what extent they are the same type of pathology. Placental insuf-
ficiency of early onset IUGR is associated with histological signs of alteration in early implanta-
tion [28]. It is not clear, however, if late IUGR is a mild form of abnormal placental implantation 
at the beginning of the pregnancy or if it is an added placental damage produced in the second 
half of pregnancy. The latter option would be supported by the fact that part of these patients 
has abnormal UtA Doppler in the third trimester being this one previously normal [29].
3. Etiology
3.1. Placental disease
In general terms, IUGR with Doppler hemodynamic alteration shows fetal adaptation to 
a hypoxia situation and chronic malnutrition due to placental insufficiency. This placental 
function alteration is caused by a deficient invasion of the trophoblast in the maternal spiral 
arteries, with an incomplete remodeling of these vessels, and therefore a deficit in the physi-
ological vasodilation that occurs in normal pregnancy. This phenomenon can be monitored 
by assessing uterine artery resistance, which increases in the cases of growth restriction asso-
ciated with placental origin [2].
It is likely that in the future, biomarkers of placental insufficiency in maternal blood may be 
incorporated as a diagnostic criterion for IUGR as markers of placental involvement in this 
pathology. Recent evidence suggests that angiogenic factors predict a poor perinatal outcome 
in small fetuses, with predictive values similar to CPR and UtA Doppler, but without a proven 
Figure 2. Sequence of changes of moderate late-onset IUGR. Adapted from Ref. [2].
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additive value [30]. An increase in anti-angiogenic factors sFlt1 and soluble endoglin (sEnd) 
and a decrease in pro-angiogenic factors (placental growth factor—PGF) have been observed.
3.2. Infectious disease
Cytomegalovirus: it is the first cause of congenital infection in Europe (0.3–0.6%). Most cases 
are asymptomatic. The risk of congenital disease is higher if the infection occurs during the 
first and second trimesters. In contrast, the transmission risk increases in the third trimester, 
but fetuses infected at this time are generally born healthy [31].
Congenital varicella: it is more frequent when the maternal disease is acquired between 8 
and 20 weeks of gestation. Very rare fetal involvement is observed in the second and third 
trimesters. There is an affectation of the musculoskeletal system and an affectation of the 
autonomic nervous system [32].
Congenital rubella: there is a higher incidence of the disease in developing countries [33]. 
Fetal involvement is observed in the vast majority of cases in which maternal infection occurs 
in the first trimester, being infrequent beyond 17 weeks.
HIV: a relationship between HIV seropositivity and the increased risk of spontaneous abor-
tion, stillbirth, IUGR, low birth weight, premature delivery, and neurodevelopmental altera-
tion [34] has been observed. The association between premature birth and low birth weight 
has also been related to the use of highly active antiretroviral therapy (HAART) [35]. In these 
patients, an increased risk of placental insufficiency has been described [36].
Malaria: this infection causes a massive sequestration of erythrocytes in the syncytiotropho-
blast. Multiple mechanisms contribute to fetal growth restriction, including abnormal vascu-
larization, impaired growth hormone expression, difficulty in transporting nutrients, and a 
process of inflammation and activation of the immune response [37].
3.3. Genetic disorders
Only 2% of the cases with fetal growth restriction without structural abnormalities are associ-
ated with alterations in the karyotype [38]. The risk of a genetic syndrome with cognitive 
repercussion is increased if there are malformations, microcephaly, and/or progressive flat-
tening of biometrics.
3.4. External factors
Smoking is the main contributor to fetal growth restriction in our environment. The odds ratio 
for developing IUGR in pregnant smokers is 1.9 (95% confidence interval (CI): 1.69–2.13). The 
risk is directly proportional to consumption [39].
4. Fetal well-being assessment
Fetal well-being assessment is based on determining whether the fetus is suffering from any 
chronic affectation (due to a progressive increase in hypoxemia and/or hypoxia) or an acute 
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involvement (acute changes in advanced stages of fetal compromise, characterized by severe 
hypoxia and metabolic acidosis) whose alteration usually precedes fetal death within a few days.
UA Doppler: it is the only measure that provides both diagnostic and prognostic information 
for IUGR management. The progression of the Doppler patterns of the UA toward an absent 
or reverse diastolic flow correlates with the risk of fetal injury or death [2].
MCA Doppler: it reports the presence of cerebral vasodilation, a subrogated hypoxia bio-
marker. Its alteration is considered a late manifestation. Fetuses with an altered MCA-PI have 
a six times higher risk of urgent cesarean section due to suspected loss of fetal well-being than 
fetuses with a normal PI [40].
CPR: it has mainly a diagnostic value. It significantly improves the sensitivity of the UA and 
the isolated MCA, since the increase in placental impedance (UA-PI) is usually combined 
with a decrease in brain resistance (MCA-PI) [41].
Ductus venosus (DV) Doppler: it is the parameter that, by itself, has the greatest capacity to 
predict the risk of short-term stillbirth in early onset IUGR. The absent/reverse flow during 
atrial contraction is associated with perinatal mortality, regardless of gestational age [42], 
with a risk ranging from 40 to 100% in the cases of early onset IUGR [43].
Aortic isthmus (AoI) Doppler: it is associated with an increase in fetal mortality and neuro-
logical morbidity in the cases of early onset IUGR. This vessel reflects the balance between 
cerebral impedance and the systemic vascular system [44]. Longitudinal studies show that 
alterations in AoI precede those of DV in 1 week [45] and, therefore, it is not a good predictor 
of short-term stillbirth risk. In contrast, AoI seems to improve the prediction of neurological 
morbidity [46].
Uterine artery Doppler (UtA): the study of the uterine artery flow has mainly focused on 
predicting the risk of preeclampsia and fetal growth restriction. However, this flow has also 
been considered both as diagnostic and fetal well-being assessment tool in SGA fetuses. There 
is a statistically significant correlation among the Doppler alteration in the UA, the Doppler 
alteration in the UtA, and an adverse perinatal outcome. Both vessels are comparable in their 
prediction ability [43].
Computerized cardiotocography (CTG): it provided with new knowledge about the patho-
physiology and management of IUGR. It evaluates the short-term variability (STV) of fetal 
heart rate, a parameter that cannot be subjectively evaluated. Current evidence suggests that 
computerized CTG is sensitive for the detection of advanced fetal impairment, and that pro-
vides a value similar to that of DV with a reverse atrial flow for the prediction of short-term 
fetal death. A low variability of fetal heart rate is correlated with the presence of acidosis and 
severe hypoxia, a fact that has been demonstrated with cord blood collected at the time of 
cesarean section. Despite the high implementation of conventional CTG in all clinical control 
protocols, it has not been shown to reduce mortality in high-risk pregnancies given its high 
inter- and intra-observer variability in interpretation [47].
Biophysical profile (BPP): it is obtained by combining ultrasound evaluation of fetal tone, 
respiratory movements, and body movements with amniotic fluid and conventional CTG. A 
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systematic review [48] found that the use of BPP does not reduce perinatal mortality (relative 
risk (RR) 1.33, 95% CI 0.60–2.98) or APGAR less than 7 at 5 min (RR 1.27, 95% CI 0.85–1.92). An 
increased risk of cesarean section was also found (RR 1.60, 95% CI 1.05–2.44). It is currently 
not recommended to perform a BPP for the control of the preterm SGA fetus.
Amniotic fluid index (AFI): it is basically used as part of the BPP. There is limited evidence 
on the role of oligoamnios as a predictor of perinatal complications in IUGR fetuses with 
Doppler follow-up, its inclusion being questionable in management protocols [2].
5. Diagnosis
5.1. Clinical diagnosis
Uterine height will be performed at each visit from 26 weeks. The methodology will be supine 
position, from fundus to pubis, and masked observation of the previous exploration. If the 
uterine height is less than the 10th percentile for gestational age and no EFW is available in 
the previous 2 weeks, an ultrasound EFW is required.
5.2. Ultrasound diagnosis
Fetal weight estimation requires three steps:
• First step: gestation dating according to crown-rump length.
• Second step: calculation of EFW according to fetal biometrics—algorithm that includes 
BPD, HC, AC, and FL [49]. If the cephalic measurements are not valuable, an alternative 
algorithm with FL and AC will be used [50].
• Third step: calculation of the growth percentile according to reference tables.
5.3. Diagnosis of the type of alteration
5.3.1. Study protocol
Detailed anamnesis:
• Toxic habits: tobacco, alcohol, drugs, medication, and work [51]
• Maternal and paternal weight and size, weight of the patient at birth, and measurement 
of blood pressure (BP) at the beginning of pregnancy
• Sexual history of the couple: relationship time. Type of contraception. Artificial fertiliza-
tion techniques
• Previous obstetric clinical history: neonatal weight of previous children (the history of 
a previous SGA doubles the risk in successive pregnancies) [52], history of fetal death, 
preeclampsia, growth restriction, repeated abortions, placental abruption, and premature 
deliveries [15]
Fetal Growth Restriction
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• Medical history: diabetes with vascular disease, moderate and severe nephropathy, 
cyanotic congenital heart disease, arterial hypertension, antiphospholipid syndrome, and 
systemic lupus erythematosus [53]
Maternal physical examination: weight, height, uterine height, limb examination in search of 
chronic vascular disease, blood pressure.
Complementary explorations:
• Ultrasound: detailed anatomical assessment. 20–60% of congenital malformations are 
accompanied by growth disturbance [54], and approximately 10% of fetuses with growth 
restriction have an associated congenital anomaly [55]. It is also important to assess 
Doppler study (UA, MCA, UtA, and CPR), placenta, amniotic fluid, and chromosomopa-
thy markers.
• Neurosonography and echocardiography: for a growth below the 3rd percentile.
• Proteinuria study.
• Complete blood test with hemogram, coagulation, and basal biochemistry (with liver and 
kidney profile).
• Amniocentesis: it is advisable to perform an amniocentesis to rule out chromosomal 
abnormalities when the diagnosis of IUGR is made at early gestational ages. The rate of 
chromosomal abnormalities in IUGR fetuses is approximately 20% if diagnosed before 
23 weeks, being practically null afterward [56]. Genetic studies in amniotic fluid are 
recommendable if any of the following criteria is met:
 ○ Quantitative fluorescence-polymerase chain reaction (QF-PCR) and molecular karyo-
type (array CGH):
 ○ IUGR diagnosis prior to 24 weeks and severe (below the 3rd percentile)
 ○ IUGR diagnosis prior to 28 weeks and severe (below the 3rd percentile) accompanied 
by ultrasound markers (excluding oligoamnios), minor structural anomaly, or biomet-
rics (FL or HC) < −3 standard deviations (SD)
 ○ EFW lower than the 10th percentile accompanied by any major structural anomaly
 ○ Study of bone alterations (add it to QF-PCR and molecular karyotype)
 ○ Achondroplasia and hypochondroplasia study if bone biometrics < −3 SD or femur/ 
foot ratio < 0.85.
 ○ Genetic counseling to assess skeletal dysplasia study if malformations associated with 
dysplasia, bone morphological alterations (fractures, curvatures, hypomineralization), 
or long bone length below the 1st percentile.
 ○ Study of specific genetic panels or exome sequencing (request genetic counseling to 
assess these studies)
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 ○ If IUGR with more than one structural anomaly of two systems (except hypospadias) 
of high syndromic risk
 ○ Biometrics (FL or HC) < −4 SD with no signs of placental insufficiency and normal 
molecular karyotype result
• Infections study: it is estimated that around 5% of SGA fetuses have an infectious cause. 
The most frequently implicated pathogen is CMV, followed by toxoplasma and syphilis 
[2]. Facing IUGR diagnosis, it is necessary to request:
 ○ Rubella study.
 ○ Syphilis study: treponemal and reaginic test in maternal blood.
 ○ Malaria study: for populations at risk (from endemic areas) [57].
 ○ CMV study: in the case of indication of invasive technique, it is necessary to perform 
CMV PCR in amniotic fluid. In the case of non-indication of invasive technique, mater-
nal serologies (IgG and IgM) will be requested only in IUGR (excludes SGA). If IgG and 
IgM are negative, the infection is discarded. If IgG and IgM are positive, it is recom-
mended to perform an amniocentesis for CMV PCR in amniotic fluid. If IgG is positive 
but IgM is negative, it is advisable to perform an amniocentesis only if there is an 
ultrasound marker compatible with CMV infection (except an isolated oligoamnios).
5.3.2. Classification
IUGR is classified into stages, as shown in Table 3:
*on two separated occasions > 12h. 
** > 50% of cycles, in free cord loop in both arteries on two separated occasions > 12h. 
*** on two separated occasions > 6-12h. 
Table 3. IUGR stages (adapted from Refs. [2, 15]).
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5.4. Follow-up
Follow-up visits for Doppler study will be adapted to the degree of fetal involvement [15]:
• SGA: control every 2–3 weeks
• IUGR stage I: control every 1–2 weeks
• IUGR stage II: control every 2–4 days
• IUGR stage III: control every 24–48 h
• IUGR stage IV: control every 12–48 h
During visits, Doppler control and CTG will be carried out. EFW assessment will be carried out 
at intervals equal to or greater than 15 days. When IUGR is accompanied by severe preeclamp-
sia, the follow-up should correspond to the follow-up of the immediately superior IUGR stage.
6. Obstetric behavior
6.1. Prenatal obstetric behavior
6.1.1. General recommendations
• Avoid complete rest, as it does not improve fetal growth or perinatal outcome [58].
• Promote the elimination of possible external factors, such as tobacco. Quitting smoking 
reduces the risk of having SGA fetus. Although the benefit is greater if tobacco is aban-
doned before 15 weeks [59], smoking cessation should be advised when diagnosing SGA 
fetus at any gestational age [60].
• Work leave is advisable [15].
• Lung maturation only if termination criteria are met and gestational age is greater than 
26 weeks (26–34.6 weeks).
• The criteria for neuroprophylaxis with magnesium sulfate will be <34 weeks and when-
ever possible >4 h before birth.
6.1.2 Termination of pregnancy: gestational age and delivery
The optimal moment of termination requires a balance between the risks of prematurity with 
those of intrauterine permanence (death and multiple organ damage due to inadequate tis-
sue perfusion) [61]. The objective of IUGR vigilance is to evaluate fetal and neonatal risks to 
optimize intervention times, as well as to choose the best route of delivery. Table 4 shows the 
recommended gestational age and delivery according to fetal growth defect.
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Depending on the gestational age when we proceed to termination, we will have various 
degrees of prematurity:
• Extreme prematurity (24–28 weeks). In this period, each additional day of pregnancy 
represents an increase of 1–2% in the chances of survival [2]. Less than 26 weeks will be 
considered in the periviable infant with chances of survival without severe sequelae below 
50% [15].
• Moderate prematurity (28–34 weeks). The presence of reverse flow in the umbilical artery 
is associated with a RR of 10.6 for the development of perinatal morbi-mortality [2].
• Late prematurity (34–36 weeks). There is not neither a high mortality rate nor severe mor-
bidity, but there is a worse perinatal and cognitive outcome [62]. The decrease in diastolic 
velocities of the umbilical artery correlates with fetal nutritional deterioration [63] and its 
neurodevelopment [64]. The fetus with absent telediastolic flow of the umbilical artery 
presents four times greater risk of severe morbidity and perinatal mortality [65].
• Full-term gestation (>37 weeks). Cerebral hemodynamic redistribution is associated with 
worse perinatal and cognitive outcome [13].
Labor in fetuses with growth restriction is associated with an increase in the rate of urgent 
cesarean sections. Therefore, in the presence of signs of severe fetal deterioration such as 
absent or reverse umbilical diastolic flow, an elective cesarean section is advised.
6.1.3. Termination methods
Cervical maturation will begin with a PGE2 slow-release device, mechanical methods, or oxy-
tocic induction depending on cervical conditions and uterine dynamics [66].
6.2. Intrapartum obstetric behavior
Continuous monitoring is necessary and an adequate resuscitation according to the baby’s 
weight. It is also important to carry out a placental anatomo-pathological study in all cases.
Table 4. Recommended gestational age and delivery according to fetal growth defect.
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6.3. Postpartum obstetric behavior
6.3.1. Immediate postpartum
• Protein/creatinine ratio and hepatic and renal profile: in those cases not studied prenatally 
and with IUGR criteria [15].
• CMV maternal serologies (IgG): to perform breast milk processing before administration 
and to avoid vertical transmission. It should be carried out in those cases with no prenatal 
studies and with IUGR criteria with delivery before 32 weeks or birth weight below 1500 g.
6.3.2. Quarantine
• Thrombophilic study: early onset IUGR, preeclampsia, or placental abruption.
• Explanation of the anatomo-pathological report of placenta. The massive deposit of perivil-
lositary fibrin is associated with a risk of recurrence of 40–60%. The patient should be informed 
of the possibility of prophylaxis with heparin in a subsequent pregnancy to reduce this risk.
7. Conclusion
FGD is an important cause of perinatal morbidity. Its diagnosis, management, and monitoring 
according to clinical evidence are very important to improve perinatal outcomes in these cases.
7.1. Recommendation and future directions
1. It is very important to improve the diagnosis of fetuses with FGD. For this reason, the first 
trimester ultrasound is essential to date the pregnancy correctly. A second trimester ultra-
sound should be performed to detect fetal anomalies and to detect the most severe and 
early cases of FGD and a third trimester ultrasound to increase the diagnosis of late FGD.
2. In those cases with risk factors for growth defects, additional ultrasounds are recom-
mended in the third trimester.
3. A careful etiological diagnosis should be done to rule out malformations, infections, or 
genetic alterations.
4. The management and follow-up of these gestations must be based on systematic protocols 
based on clinical evidence that facilitate the unification of clinical practice.
Abbreviations
IUGR intrauterine growth restriction
SGA small for gestational age
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FGD fetal growth defect
EFW estimated fetal weight
BPD biparietal diameter
HC head circumference
AC abdominal circumference
FL femur length
CPR cerebroplacental ratio
MCA middle cerebral artery
PI pulsatility index
UA umbilical artery
UtA uterine artery
HIV human immunodeficiency virus
HAART highly active antiretroviral therapy
DV ductus venosus
CTG computerized cardiotocography
BPP biophysical profile
STV short-term variability
RR relative risk
CI confidence interval
AFI amniotic fluid index
BP blood pressure
QF-PCR quantitative fluorescence-polymerase chain reaction
PCR polymerase chain reaction
SD standard deviation
IgG immunoglobulin G
IgM immunoglobulin M
PGE
2
 prostaglandin E
2
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